Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome / Edition 2

Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome / Edition 2

by Ronald A. Codario
ISBN-10:
1603274405
ISBN-13:
9781603274401
Pub. Date:
11/01/2010
Publisher:
Springer-Verlag New York, LLC

Hardcover - Rent for

Select a Purchase Option (2nd ed. 2011)
  • purchase options
    $77.86 $99.00 Save 21% Current price is $77.86, Original price is $99. You Save 21%.
  • purchase options

Overview

Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome / Edition 2

This second edition will feature updates for all chapters, including references as needed and, most importantly, the latest outcomes data for lipids, hypertension and overall risk reduction. It will also include a new chapter on incretins, amylin analogues and DPP-IV inhibitors as well as an expanded section on lipid disorders in the diabetic patient. New information on the role of the incretin system in the pathophysiology of the disease will also be detailed. Existing chapters will be edited for better brevity to accommodate the new chapters being added and to contain the length of the book to approximately 250 to 300 pages. Although it will not include CME certification, the feature of several multiple choice questions will be retained at the end of each chapter to add value.

Product Details

ISBN-13: 9781603274401
Publisher: Springer-Verlag New York, LLC
Publication date: 11/01/2010
Series: Current Clinical Practice Series
Edition description: 2nd ed. 2011
Pages: 367
Product dimensions: 7.10(w) x 10.10(h) x 1.10(d)

Table of Contents

Introduction

Chapter One: Pathophysiology of Type-2 Diabetes
Chapter Two: Guidelines and Classifications
Chapter Three: Exercise
Chapter Four: Nutrition
Chapter Five: Obesity and the Metabolic Syndrome
Chapter Six: Oral Agents for Type-2 Diabetes
Chpater Seven: Insulin Use
Chapter Eight: Non- Insulin Injectables
Chapter Nine: Macrovascular Disease
Chapter Ten: Microvascular Disease
Chapter Eleven: Diabetic Dyslipidemia
Chapter Twelve: Hypertension in Diabetics
Chapter Thirteen: The Pathophysiology and Metabolic Impact of Hyperglycemia
Chapter Fourteen: Risk Reduction in the Diabetic Patient
Chapter Fifteen: Special Populations

Resources

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews